Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Vincent Paul Liptak

General Counsel at BlossomHill Therapeutics, Inc. (BLSM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$7K
Total bought / sold$75K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 10SEC BLSMBlossomHill Therapeutics, Inc. Buy 2,500109,212 held (+2%) $15.80 $40K +10.6%
Aug 10SEC BLSMBlossomHill Therapeutics, Inc. Buy 2,200111,412 held (+2%) $16.00 $35K +9.3%
  • Buy

    General Counsel Vincent Paul Liptak bought $40K of BLSM at $15.80 — first open-market purchase in our records.